During density-gradient centrifugation, cells move through the density medium according to their buoyant density. Components continue migrating until their movement is balanced by the surrounding medium, so cells with lower density remain higher in the gradient or near its interface. This physical behavior allows investigators to collect a fraction enriched for selected low-density cellular populations.
Some granulocytes and myeloid cells associated with activation or immaturity have physical properties that place them among lower-density components during centrifugation. Their recovery in the low-density fraction therefore provides a way to examine cellular states linked to inflammation and disease. Researchers can then characterize these populations rather than analyzing only the denser blood-cell compartment.
The main distinction is the position cells occupy after centrifugation and the density characteristics that determine that position. Denser blood cells migrate farther into the density medium, whereas lower-density populations remain in the upper layer or at the interface. Comparing these fractions can help investigators determine whether disease-associated or activated cells are preferentially enriched in the low-density compartment.
The density medium creates the physical separation environment needed for cells to migrate according to buoyant density. Its density establishes the point at which movement becomes balanced and defines where lower-density material can be collected. Because the recovered population depends on this separation behavior, the medium is central to distinguishing the target fraction from denser blood cells and debris.
A typical workflow uses density-gradient centrifugation to move sample components through a density medium. After centrifugation, the operator identifies the low-density layer or interface, collects that material separately, and distinguishes it from denser blood cells and debris. The recovered fraction can then be prepared for phenotyping, functional testing, or molecular analysis.
The fraction can support several complementary analyses, including phenotyping, functional assays, and transcriptomic analysis. Phenotyping characterizes the cellular populations present, functional assays examine their responses or activities, and transcriptomic analysis evaluates gene-expression patterns. Using these approaches together can connect the identity of enriched immune cells with their biological state and behavior.
Investigators use it to study circulating immune-cell populations that may change during inflammation, infection, or other disease-associated states. Enrichment of low-density granulocytes and other activated or immature myeloid cells supports analysis of host responses and cellular changes linked to disease. The approach is therefore useful when the research question concerns altered immune-cell composition or function.
Collection enriches low-density populations but does not, by itself, establish that the sample contains only one cell type. Low-density granulocytes and other activated or immature myeloid cells may be examined within the recovered material, while phenotyping can help characterize which populations are present. This distinction matters when interpreting functional or transcriptomic results from the fraction.